BERLIN (Reuters) -German pharma company Bayer reported positive study results for its anticoagulant asundexian on Sunday, two years after a research setback for the promising blood thinner candidate.
In a Phase III study, a daily dose of 50 milligrams significantly reduced the risk of ischemic stroke compared with a placebo, Bayer said.
Detailed results from the OCEANIC-STROKE study will be presented at an upcoming scientific congress, said Bayer.
Bayer added that it plans to speak with health authorities worldwide in preparation for the submission of marketing authorisation applications.
Bayer had originally predicted that asundexian would have peak sales potential of more than 5 billion euros ($5.76 billion) - more than any of its other drugs.
At the end of 2023, the company had a major setback with the drug after it failed in a pivotal clinical trial involving patients with atrial fibrillation and a risk of stroke.
($1 = 0.8687 euros)
(Reporting by Joern Poltz. Writing by Miranda Murray. Editing by Jane Merriman)
LATEST POSTS
- 1
Flying without a Real ID? That'll soon cost you $45, TSA says. - 2Stolen Renoir, Cézanne and Matisse were probably uninsured, market sources say
- 3Step by step instructions to Streamline Your Dozing Involvement in a Savvy Bed
- 4How stripping diversity, equity and inclusion from health care may make Americans sicker
- 5Hyundai Is Keeping the i30 Alive While America Keeps Losing Cars Like It
- The most effective method to Make a Dazzling Site in 5 Basic Advances
- Vote In favor of Your #1 Compelling Female Producer
- Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution
- Purchases of iPhone 17 Pro soar across Gaza amid 'limited' humanitarian aid
- RFK Jr.’s vaccine advisers plan biggest change yet to childhood schedule
- I'm a woman who's into weightlifting. Was I man enough for the creatine-packed 'Man Cereal'?
- Vote in favor of the bloom plan that adds a bit of excellence to your life!
- Criminal Guard Lawyer Expenses: What Would it be advisable for you to Hope to Pay?
- Family Matters: Tips and Guidance for Effective Nurturing and Everyday Life
